Telemedicine Suitability by Trial Phase and Therapeutic Area in DCTs
Clinical trials typically progress through four main phases:
Click to read the full article.
Decentralized Clinical Trials (DCTs)
Overcoming Licensing and Regulatory Barriers in Cross-State and International Telemedicine
Telemedicine services are typically regulated at the jurisdictional level, and healthcare providers must hold valid licenses in the region where the patient is located—not just where the provider operates. This legal principle complicates telehealth delivery across:
Click to read the full article.
Patient Satisfaction and Adherence with Telehealth in Clinical Trials
High levels of satisfaction and adherence are vital for DCT success. They impact:
Click to read the full article.
Training Investigators for Virtual Interactions in Decentralized Clinical Trials
Virtual settings change the dynamics of communication, documentation, and patient management. Investigators need tailored training to:
Click to read the full article.
Data Protection in Telemedicine for Clinical Trials
Clinical trials generate personal health information (PHI) and medical records that are legally protected. Failing to safeguard such data can lead to:
Click to read the full article.
Coordinating Home Nurse Visits for Study Procedures in Decentralized Trials
Bringing clinical procedures into patients’ homes can significantly enhance:
Click to read the full article.
Ensuring Protocol Compliance During Home Visits in Decentralized Trials
In DCTs, home visits must uphold the same clinical rigor as on-site interactions. Non-compliance can lead to:
Click to read the full article.
Supply Chain Considerations for Home-Based Dosing in Decentralized Clinical Trials
Unlike traditional site-based studies, home-based dosing introduces:
Click to read the full article.
Training Home Healthcare Providers for Decentralized Clinical Trials
In a decentralized model, the responsibilities traditionally handled by site-based staff are often shifted to home care professionals. Without structured training, this transition may result in:
Click to read the full article.
Patient Safety and Emergency Preparedness at Home in Decentralized Clinical Trials
Unlike in-clinic settings, home environments vary greatly in layout, resources, and emergency readiness. Regulatory agencies such as the CDSCO emphasize that the sponsor remains responsible for participant safety regardless of trial location. Therefore, a proactive risk mitigation strategy must be part of the protocol design for all home-based studies.
Click to read the full article.